CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 

Wright Current Income Fund - 25th anniversary

 
 
 
 
 
 
Bioton SA Company Snapshot
Bioton SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bioton SA with three other pharmaceutical manufacturers in Europe: Evotec AG of Germany (2013 sales of 85.94 million Euro [US$109.75 million] of which 100% was Drug Discovery & Development), SkyePharma PLC of the United Kingdom (£62.60 million [US$102.29 million] of which 100% was Pharmaceuticals), and Olainfarm AS which is based in Latvia (77.96 million Latvian Lats [US$99.56 million] ).

Sales Analysis. During the year ended December of 2013, sales at Bioton SA were 340.36 million Polish New Zlotys (US$104.18 million). This is a decrease of 16.2% versus 2012, when the company's sales were 406.30 million Polish New Zlotys. Contributing to the drop in overall sales was the 96.5% decline in Copernicus, from 1.81 million Polish New Zlotys to 64,000.00 Polish New Zlotys. There were also decreases in sales in Pharmatex (down 28.6% to 26.14 million Polish New Zlotys) and Fisiopharma (down 21.5% to 18.95 million Polish New Zlotys) and Biolek (down 24.4% to 62,000.00 Polish New Zlotys) . However, these declines were partially offset by the increase in sales of Insulin (Bioton Sa) (up 32.5% to 159.92 million Polish New Zlotys) and Mj Biopharm (up 2.0% to 73.60 million Polish New Zlotys) and Scigen Group (up 8.6% to 61.62 million Polish New Zlotys) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Bioton SA
  Stock Performance Chart for Bioton SA
 
  Stock Data: Recent Stock Performance:
  Current Price (9/26/2014): 4.85
(Figures in Polish New Zlotys)
1 Week 3.4%   13 Weeks 0.4%  
4 Weeks -11.3%   52 Weeks 142.5%  
 
Bioton SA Key Data:
  Ticker: BIO Country: Poland
  Exchanges: WAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2013 Sales 340,358,000
(Year Ending Jan 2014).
Employees: 1,026
  Currency: Polish New Zlotys Market Cap: 416,441,370
  Fiscal Yr Ends: December Shares Outstanding: 85,864,200
  Share Type: Akcje Closely Held Shares: 18,673,053
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.